A bone regeneration device using bioactive materials pioneered by Querrey Simpson Institute for Regenerative Engineering at Northwestern University (QSI RENU) director Guillermo Ameer was recently ...

ALLENDALE, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Acuitive Technologies ® commercializes Citregraft™, with its first use in a surgical case, performed on November 4 th, 2025. Bone graft substitutes ...

Acuitive Technologies earned FDA clearance for the Citrepore bioactive bone filler, the company said Nov. 12. 1. Citrate is designed for orthopedic surgery and is made with the company’s patented ...

ALLENDALE, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Acuitive Technologies, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market CITREPORE, a ...

The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several ...

ROCKLAND, Mass.--(BUSINESS WIRE)-- Paradigm BioDevices, Inc., “The Leader in MIS Bone Graft Harvesting,” is pleased to announce the completion of 40,000 procedures utilizing the QUICKDRAW MIS Bone ...

Many surgeons have reported results similar to those of anterior debridement and bone grafting in treating spinal tuberculosis in the lumbar region using only a posterior approach. However, there is ...